Childhood mature teratoma of the ovary

Summary

Childhood mature teratoma of the ovary (MONDO:0003818) is a disease. A subtype of childhood teratoma of the ovary — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood mature teratoma of the ovary
Mondo ID	MONDO:0003818
DOID	DOID:6229
NCIT	C6548
UMLS	C1332991
MedGen	232354
GARD	0023681
Is cancer (heuristic)	no

Also known as: childhood mature ovarian teratoma · childhood mature teratoma of ovary · childhood ovarian mature teratoma · mature ovarian teratoma of childhood · paediatric mature ovarian teratoma · paediatric mature teratoma of ovary · paediatric mature teratoma of the ovary · paediatric ovarian mature teratoma · pediatric mature ovarian teratoma · pediatric mature teratoma of ovary · pediatric mature teratoma of the ovary · pediatric ovarian mature teratoma

Disease family

This is a subtype of childhood teratoma of the ovary. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › childhood germ cell tumor › pediatric ovarian germ cell tumor › childhood teratoma of the ovary › childhood mature teratoma of the ovary

Related subtypes (1): childhood immature teratoma of ovary

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.